Mondello, P., Steiner, N., Willenbacher, W., Cerchione, C., Nappi, D., Mauro, E., . . . Mian, M. (2018). Bendamustine plus Rituximab Versus R‐CHOP as First‐Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Oncologist.
শিকাগো স্টাইলে সাইটেশনMondello, Patrizia, Normann Steiner, Wolfgang Willenbacher, Claudio Cerchione, Davide Nappi, Endri Mauro, Simone Ferrero, Salvatore Cuzzocrea, এবং Michael Mian. "Bendamustine Plus Rituximab Versus R‐CHOP As First‐Line Treatment for Patients With Follicular Lymphoma Grade 3A: Evidence From a Multicenter, Retrospective Study." Oncologist 2018.
এমএলএ সাইটেশনMondello, Patrizia, et al. "Bendamustine Plus Rituximab Versus R‐CHOP As First‐Line Treatment for Patients With Follicular Lymphoma Grade 3A: Evidence From a Multicenter, Retrospective Study." Oncologist 2018.